CONVERGIS - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 85547252
Serial Number
85547252
Word Mark
CONVERGIS
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2016-01-18
Filing Date
2012-02-20
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2012-10-23
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
LAVACHE, LINDA M
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Veterinary preparations for destroying vermin, namely, insecticides for use with livestock and livestock premises; antibiotics for use in livestock; veterinary preparations for the treatment of enteric clostridium infections; veterinary preparations for the prevention of enteric clostridium infections; veterinary preparations in the treatment of Cushing's disease in animals; veterinary preparations for the control and symptomatic relief of viral and bacterial infectious diseases of cattle; immunorestorative biopharmaceutical for enhancing the immune system of cattle; veterinary preparations for controlling and destroying vermin, namely, insecticides and pesticides for use with poultry and livestock animals and poultry and livestock premises; veterinary preparations, namely, vaccines, antimicrobials and other medicinal drugs for the prevention, treatment, control, or symptomatic relief of infectious, non-infectious and metabolic diseases of poultry and livestock; animal feed supplements; medicated feed and water additives for animals; veterinary preparations for food safety, namely, anti-microbial preparations for inhibiting microbiological decomposition in food and animal feed; veterinary preparations, namely, anti-microbials and vaccines for food safety and food animal processing; antibacterial pharmaceuticals; veterinary preparations for production improvement for poultry and livestock, namely, medicated feed additives for poultry and livestock and medicated water additives for poultry and livestock; diagnostic agents, preparations and substances to identify pathogens or residues of biological interest for veterinary use; bactericides, namely, bacteriophage used as a human food safety agent to reduce levels of food borne pathogens carried on livestock or meat prior to being processed for human consumption; bacterial vector based vaccines relating to infection and non-infectious diseases or productivity loss in all avian, ruminant and swine species, the prevention or reduction of contamination of food produced by any or all avian, ruminant or swine species, the prevention of food-borne diseases in humans associated with contact with or consumption of food produced by any or all avian, ruminant or swine species; pathogen reduction preparations for pathogens that are in or on animals and that take the form of bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; pathogen reduction treatment preparation for use in treating bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; veterinary preparations containing natural plant extracts for oral administration to avian species and other livestock as an aid in managing health risks and productivity, namely, veterinary preparations for infection and non-infectious diseases or productivity loss in avian species and other livestock; Veterinary preparations for use in the treatment of fleas on pets; veterinary preparations for use in the prevention of fleas on pets; insecticides to prevent fleas on pets; transdermal drug delivery products for use on companion and food animals, namely, skin penetration medicine for pain and inflammation; veterinary preparations for companion animals in the treatment of parasitic infestations; transdermal topical solution administered by veterinarians in a surgical setting to treat pain in companion animals; veterinary preparations for companion animals in the treatment of anxiety, diabetes, hyperthyroidism, hypothyroidism, obesity, urine spraying, urinary incontinence; veterinary preparations for companion animals in the treatment of dental and oral disease, namely, stomatitis, Feline Odontoclastic Resorptive Lesion, periodontitis; veterinary preparations for companion animals in the treatment of chronic pain associated with osteoarthritis and cancer; veterinary preparations for companion animals in the treatment of gastrointestinal disorders associated with cholangiohepatitis, inflammatory bowel disorder, pancreatitis, gastritis, chronic colitis, enteritis; veterinary preparations for companion animals in the treatment of central nervous systems diseases and disorders, namely, cerebellar hypoplasia, cerebellar abiotrophy, laryngeal paralysis, meningoencephalitis, syringomyelia; veterinary preparations for companion animals in the treatment of neurological and neurodegenerative disorders, namely, seizure, epilepsy, neuropathies; veterinary preparations for companion animals in the treatment of parasitic infections and infestations associated with acaricides, heartworm, GI nematodes, mange, fleas; veterinary preparations for companion animals in the treatment of cardiovascular conditions, namely, hypertension, cardiomyopathies, heart murmurs, heart failure; veterinary preparations for companion animals in the treatment of dermatologic conditions, namely, canine atopic dermatitis, skin rash, flea allergy, food allergy, cancer; veterinary preparations for companion animals in the treatment of chronic kidney disease and associated conditions, namely, anemia, hyperphosphatemia, hypocalcemia, hypertension, cachexia; veterinary preparations for companion animals in the treatment of acute pain associated with orthopedic and soft tissue surgery, trauma, and musculoskeletal conditions; veterinary preparations for companion animals in the treatment of osteoarthritis, otitis and wound healing; veterinary preparations for companion animals in the treatment of upper respiratory infections; veterinary preparations for companion animals in the treatment of allergy atopic conditions associated with atopic dermatitis, seasonal allergies, asthma; veterinary preparations for companion animals in the treatment of liver disease, acute and chronic hepatitis
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2012-02-27
Primary Code
005
Correspondences
Name
ROBERT E. LEE, JR.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2012-02-23NEW APPLICATION ENTERED IN TRAM
2012-02-27NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2012-03-23ASSIGNED TO EXAMINER
2012-03-28NON-FINAL ACTION WRITTEN
2012-03-28NON-FINAL ACTION E-MAILED
2012-03-28NOTIFICATION OF NON-FINAL ACTION E-MAILED
2012-08-31TEAS RESPONSE TO OFFICE ACTION RECEIVED
2012-08-31CORRESPONDENCE RECEIVED IN LAW OFFICE
2012-09-01TEAS/EMAIL CORRESPONDENCE ENTERED
2012-09-04APPROVED FOR PUB - PRINCIPAL REGISTER
2012-09-04TEAS RESPONSE TO OFFICE ACTION RECEIVED
2012-09-06PREVIOUS ALLOWANCE COUNT WITHDRAWN
2012-09-04CORRESPONDENCE RECEIVED IN LAW OFFICE
2012-09-06TEAS/EMAIL CORRESPONDENCE ENTERED
2012-09-06EXAMINERS AMENDMENT -WRITTEN
2012-09-06EXAMINERS AMENDMENT E-MAILED
2012-09-06NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2012-09-06EXAMINER'S AMENDMENT ENTERED
2012-09-06APPROVED FOR PUB - PRINCIPAL REGISTER
2012-09-15ASSIGNED TO LIE
2012-09-17LAW OFFICE PUBLICATION REVIEW COMPLETED
2012-10-03NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2012-10-23PUBLISHED FOR OPPOSITION
2012-10-23OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2012-12-18NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2013-06-11TEAS EXTENSION RECEIVED
2013-06-11EXTENSION 1 FILED
2013-06-11EXTENSION 1 GRANTED
2013-06-13NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2013-12-03TEAS EXTENSION RECEIVED
2014-01-24CASE ASSIGNED TO INTENT TO USE PARALEGAL
2013-12-03EXTENSION 2 FILED
2014-02-04EXTENSION 2 GRANTED
2014-02-05NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2014-06-10TEAS EXTENSION RECEIVED
2014-06-10EXTENSION 3 FILED
2014-06-12EXTENSION 3 GRANTED
2014-06-13NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2014-12-11TEAS EXTENSION RECEIVED
2014-12-11EXTENSION 4 FILED
2014-12-22EXTENSION 4 GRANTED
2014-12-23NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2015-05-22TEAS EXTENSION RECEIVED
2015-05-22EXTENSION 5 FILED
2015-06-10EXTENSION 5 GRANTED
2015-06-11NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2016-01-18ABANDONMENT - NO USE STATEMENT FILED
2016-01-19ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED